Enliven Therapeutics, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Enliven Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Enliven Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -29.3 %, a 39.5% increase year-over-year.
  • Enliven Therapeutics, Inc. annual Return On Equity for 2023 was -26.6 %, a 145% decline from 2022.
  • Enliven Therapeutics, Inc. annual Return On Equity for 2022 was 59.3 %.
  • Enliven Therapeutics, Inc. annual Return On Equity for 2021 was -50.2 %, a 13.2% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -26.6 -85.8 -145% Jan 1, 2023 Dec 31, 2023
2022 59.3 +109 Jan 1, 2022 Dec 31, 2022
2021 -50.2 +7.65 +13.2% Jan 1, 2021 Dec 31, 2021
2020 -57.9 -118 -197% Jan 1, 2020 Dec 31, 2020
2019 59.9 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.